Elke Tatjana Aristizabal Prada

Primary Aldosteronism

Yuhong Yang, Celso E. Gómez-Sánchez, Diana Jaquin et al. · Hypertension · 2019 · 43 citations · Full text

Synergistic Highly Potent Targeted Drug Combinations in Different Pheochromocytoma Models Including Human Tumor Cultures

Maria Fankhauser, Nicole Bechmann, Michael Lauseker et al. · Endocrinology · 2019 · 40 citations · Full text

The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models

Svenja Nölting, Jakob Rentsch, Helma Freitag et al. · PLoS ONE · 2017 · 33 citations · Full text

The HDM2 (MDM2) Inhibitor NVP-CGM097 Inhibits Tumor Cell Proliferation and Shows Additive Effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 Cascade in the p53<sup>wild type</sup> Neuroendocrine Tumor Cell Line GOT1

Clemens Reuther, Vera Heinzle, Svenja Nölting et al. · Neuroendocrinology · 2016 · 26 citations · Full text

The role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance

Elke Tatjana Aristizabal Prada, Gerald Spöttl, Julian Maurer et al. · Endocrine Related Cancer · 2018 · 26 citations · Full text